HiloProbe Overview

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

HiloProbe General Information

Description

Operator of a research-based company intended to develop diagnostics medical techniques for cancer treatment. The company allows accurate analysis of the spread of cancer cells into lymph nodes as well as detection and characterization of lymph nodes of colorectal cancer, enabling doctors and medical professionals to understand about aggressive cancer cells are and select the appropriate treatment for the patient.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeå
  • Sweden
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Biotechnology
Drug Discovery
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeå
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HiloProbe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Bankruptcy: Liquidation 11-Nov-2024 Completed Bankruptcy: Liquidation
7. Later Stage VC 06-Nov-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
5. Grant 05-Oct-2020 Completed Generating Revenue
4. Early Stage VC 01-Jan-2018 Completed Generating Revenue
3. Grant 30-Dec-2017 Completed Generating Revenue
2. Grant 31-Mar-2017 $11.2K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view HiloProbe’s complete valuation and funding history, request access »

HiloProbe Patents

HiloProbe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2981481-T3 Marker genes for colorectal cancer classification, method for judging lymph node metastasis for colorectal cancer prognosis and kit for it Active 20-Apr-2016
AU-2017254347-A1 Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor Active 20-Apr-2016
AU-2017254347-B2 Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor Inactive 20-Apr-2016
EP-3446122-A1 Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor Active 20-Apr-2016
EP-3446122-A4 Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor Active 20-Apr-2016 C12Q1/6886
To view HiloProbe’s complete patent history, request access »

HiloProbe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HiloProbe FAQs

  • Where is HiloProbe headquartered?

    HiloProbe is headquartered in Umeå, Sweden.

  • What is the size of HiloProbe?

    HiloProbe has 3 total employees.

  • What industry is HiloProbe in?

    HiloProbe’s primary industry is Decision/Risk Analysis.

  • Is HiloProbe a private or public company?

    HiloProbe is a Private company.

  • What is HiloProbe’s current revenue?

    The current revenue for HiloProbe is .

  • How much funding has HiloProbe raised over time?

    HiloProbe has raised $285K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process